John P. McLaughlin
2017
In 2017, John P. McLaughlin earned a total compensation of $3.4M as Chief Executive Officer at PDL BioPharma, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,490,234 |
|---|---|
| Salary | $717,003 |
| Stock Awards | $1,200,000 |
| Other | $10,000 |
| Total | $3,417,237 |
McLaughlin received $1.5M in non-equity incentive plan, accounting for 44% of the total pay in 2017.
McLaughlin also received $717K in salary, $1.2M in stock awards and $10K in other compensation.
Rankings
In 2017, John P. McLaughlin's compensation ranked 3,096th out of 14,666 executives tracked by ExecPay. In other words, McLaughlin earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,096 out of 14,666 | 79th |
Division Manufacturing | 1,066 out of 5,768 | 82nd |
Major group Chemicals And Allied Products | 289 out of 2,074 | 86th |
Industry group Drugs | 220 out of 1,730 | 87th |
Industry Biological Products, Except Diagnostic Substances | 41 out of 316 | 87th |
Source: SEC filing on April 26, 2018.
McLaughlin's colleagues
We found five more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2017.